Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02295891 · ClinicalTrials.gov registry record · NA
Miradry Treatment for Focal Axillary Hyperhidrosis
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT02295891: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT02295891 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02295891, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Primary hyperhidrosis is a pathological condition characterized by the idiopathic and excessive secretion of sweat beyond normal physiological demand and is localized at particular foci such as the face, axilla, palms of the hands, and soles of the feet. Patients seeking medical attention for hyperhidrosis often report disruptions to their professional and/or social lives due to sweating and subsequently experience many psychosocial difficulties, such as anxiety, social phobia, and depression. Therefore, a psychiatric explanation of causality is frequently offered for these patients during diagnosis. Excessive sweating is often mistakenly interpreted as a symptom of an anxiety disorder and can be cause for social embarrassment, exacerbating emotional stress and social avoidance. As currently constituted, the treatment of secondary psychosocial symptoms in primary hyperhidrosis is poorly understood and requires further investigation.
Interventions
- DEVICE MiraDry ®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02295891
The ClinicalTrials.gov registry entry for NCT02295891 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MiraDry ® is the first listed.
NCT02295891 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02295891 about?
NCT02295891 is a clinical study titled "Miradry Treatment for Focal Axillary Hyperhidrosis". Primary hyperhidrosis is a pathological condition characterized by the idiopathic and excessive secretion of sweat beyond normal physiological demand and is localized at particular foci such as the face, axilla, palms of the hands, and soles of the feet. Patients seeking medical attention for hyperh...
What is the current status of trial NCT02295891?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2014-11. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02295891?
The interventions under investigation include: MiraDry ® (DEVICE).
Who is sponsoring clinical trial NCT02295891?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.